Anders Martin-Löf has been appointed as the new CFO of Oncopeptides
Stockholm – August 9, 2018 - Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today that Anders Martin-Löf, has been appointed as the new CFO of Oncopeptides and will join the company in November.CFO Birgitta Ståhl has decided to step down as the CFO as the Company expands the organization in Europe and the US, following a successful preparation and execution of Oncopeptides’ IPO. She will continue to work in the Company. Anders has extensive life science experience in financial, strategic and commercial positions in both public and private entities. The last decade he has been the CFO